Cited by 310Toxic Organic Pollutants ImpactPharmacogenetics and Drug MetabolismCarcinogens and Genotoxicity Assessment

A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors

Open access
Andersson, Patrik, McGuire, Jacqueline, Rubio, Carlos, Gradin, Katarina, Whitelaw, Murray L., Pettersson, Sven, Hanberg, Annika, Poellinger, Lorenz·2002·Proceedings of the National Academy of Sciences

Abstract

The dioxin/aryl hydrocarbon receptor (AhR) functions as a ligand-activated transcription factor regulating transcription of a battery of genes encoding xenobiotic metabolizing enzymes. Known receptor ligands are environmental pollutants including polycyclic aromatic hydrocarbons and polychlorinated dioxins. Loss-of-function (gene-disruption) studies in mice have demonstrated that the AhR is involved in toxic effects of dioxins but have not yielded unequivocal results concerning the physiological function of the receptor. Gain-of-function studies therefore were performed to unravel the biological functions of the AhR. A constitutively active AhR expressed in transgenic mice reduced the life span of the mice and induced tumors in the glandular part of the stomach, demonstrating the oncogenic potential of the AhR and implicating the receptor in regulation of cell proliferation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.152706299

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AHR mutants lacking the PAS B domain constitutively dimerize with ARNT, bind AHREs, and induce AHRE-driven genes independently of ligand.

    “Early evidence from domain mapping studies demonstrated that Ahr mutants lacking the PAS B domain constitutively dimerize with ARNT, bind to AHREs, and induce transcription of AHRE-driven genes in a manner that is independent of ligand binding (Andersson et al., 2002; J. McGuire et al., 2001).”

    From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Andersson et al., 2002

    The Results report that an AhR mutant lacking amino acids 288–421 of the ligand-binding domain cannot bind ligand but constitutively activates a reporter gene; they also report induction of AhR target genes. Our copy does not identify the deleted portion as PAS B or show that the mutant constitutively dimerizes with ARNT or binds AHREs. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 33

  1. [1]Gu Y Z, Hogenesch J B, Bradfield C A. Annu Rev Pharmacol Toxicol. 2000;40:519–561. doi: 10.1146/annurev.pharmtox.40.1.519. [DOI] [PubMed] [Google Scholar] · DOI
  2. [2]Pohjanvirta R, Tuomisto J. Pharmacol Rev. 1994;46:483–549. [PubMed] [Google Scholar]
  3. [3]Shimizu Y, Nakatsuru Y, Ichinose M, Takahashi Y, Kume H, Mimura J, Fujii-Kuriyama Y, Ishikawa T. Proc Natl Acad Sci USA. 2000;97:779–782. doi: 10.1073/pnas.97.2.779. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  4. [4]Fernandez-Salguero P, Pineau T, Hilbert D M, McPhail T, Lee S S, Kimura S, Nebert D W, Rudikoff S, Ward J M, Gonzalez F J. Science. 1995;268:722–726. doi: 10.1126/science.7732381. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  5. [5]Schmidt J V, Su G H, Reddy J K, Simon M C, Bradfield C A. Proc Natl Acad Sci USA. 1996;93:6731–6736. doi: 10.1073/pnas.93.13.6731. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  6. [6]Mimura J, Yamashita K, Nakamura K, Morita M, Takagi T N, Nakao K, Ema M, Sogawa K, Yasuda M, Katsuki M, Fujii-Kuriyama Y. Genes Cells. 1997;2:645–654. doi: 10.1046/j.1365-2443.1997.1490345.x. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  7. [7]Fernandez-Salguero P M, Ward J M, Sundberg J P, Gonzalez F J. Vet Pathol. 1997;34:605–614. doi: 10.1177/030098589703400609. [DOI] [PubMed] [Google Scholar] · DOI
  8. [10]Bodrug S E, Warner B J, Bath M L, Lindeman G J, Harris A W, Adams J M. EMBO J. 1994;13:2124–2130. doi: 10.1002/j.1460-2075.1994.tb06488.x. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  9. [11]Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning: A Laboratory Manual. Plainview, NY: Cold Spring Harbor Lab. Press; 1989. [Google Scholar]
  10. [12]Gradin K, Toftgård R, Poellinger L, Berghard A. J Biol Chem. 1999;274:13511–13518. doi: 10.1074/jbc.274.19.13511. [DOI] [PubMed] [Google Scholar] · DOI
  11. [13]Mangelsdorf D J, Evans R M. Cell. 1995;83:841–850. doi: 10.1016/0092-8674(95)90200-7. [DOI] [PubMed] [Google Scholar] · DOI
  12. [14]Whitelaw M L, Göttlicher M, Gustafsson J Å, Poellinger L. EMBO J. 1993;12:4169–4179. doi: 10.1002/j.1460-2075.1993.tb06101.x. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  13. [15]Jenuwein T, Grosschedl R. Genes Dev. 1991;5:932–943. doi: 10.1101/gad.5.6.932. [DOI] [PubMed] [Google Scholar] · DOI
  14. [16]Mimura J, Ema M, Sogawa K, Fujii-Kuriyama Y. Genes Dev. 1999;13:20–25. doi: 10.1101/gad.13.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  15. [17]Fletcher N, Hanberg A, Håkansson H. Toxicol Sci. 2001;62:166–175. doi: 10.1093/toxsci/62.1.166. [DOI] [PubMed] [Google Scholar] · DOI
  16. [18]Stemmermann G N. Cancer. 1994;74:556–564. doi: 10.1002/1097-0142(19940715)74:2<556::aid-cncr2820740205>3.0.co;2-j. [DOI] [PubMed] [Google Scholar] · DOI
  17. [19]Endoh Y, Tamura G, Motoyama T, Ajioka Y, Watanabe H. Hum Pathol. 1999;30:826–832. doi: 10.1016/s0046-8177(99)90144-2. [DOI] [PubMed] [Google Scholar] · DOI
  18. [20]Kleman M I, Poellinger L, Gustafsson J Å. J Biol Chem. 1994;269:5137–5144. [PubMed] [Google Scholar]
  19. [21]Kleman M I, Övervik E, Mason G G, Gustafsson J Å. Carcinogenesis. 1992;13:1619–1624. doi: 10.1093/carcin/13.9.1619. [DOI] [PubMed] [Google Scholar] · DOI
  20. [22]Parkin D M, Pisani P, Ferlay J. Int J Cancer. 1999;80:827–841. doi: 10.1002/(sici)1097-0215(19990315)80:6<827::aid-ijc6>3.0.co;2-p. [DOI] [PubMed] [Google Scholar] · DOI
  21. [23]Stadtländer C T, Waterbor J W. Carcinogenesis. 1999;20:2195–2208. doi: 10.1093/carcin/20.12.2195. [DOI] [PubMed] [Google Scholar] · DOI
  22. [24]Ekström A M, Eriksson M, Hansson L E, Lindgren A, Signorello L B, Nyrén O, Hardell L. Cancer Res. 1999;59:5932–5937. [PubMed] [Google Scholar]
  23. [25]Svensson B G, Mikoczy Z, Strömberg U, Hagmar L. Scand J Work Environ Health. 1995;21:106–115. doi: 10.5271/sjweh.17. [DOI] [PubMed] [Google Scholar] · DOI
  24. [26]Milstone L M, LaVigne J F. J Invest Dermatol. 1984;82:532–534. doi: 10.1111/1523-1747.ep12261149. [DOI] [PubMed] [Google Scholar] · DOI
  25. [27]Elizondo G, Fernandez-Salguero P, Sheikh M S, Kim G Y, Fornace A J, Lee K S, Gonzalez F J. Mol Pharmacol. 2000;57:1056–1063. [PubMed] [Google Scholar]
  26. [28]Ma Q, Whitlock J P. Mol Cell Biol. 1996;16:2144–2150. doi: 10.1128/mcb.16.5.2144. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  27. [29]Kolluri S K, Weiss C, Koff A, Göttlicher M. Genes Dev. 1999;13:1742–1753. doi: 10.1101/gad.13.13.1742. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  28. [30]Ceci J D, Kovatch R M, Swing D A, Jones J M, Snow C M, Rosenberg M P, Jenkins N A, Copeland N G, Meisler M H. Oncogene. 1991;6:323–332. [PubMed] [Google Scholar]
  29. [31]Searle P F, Thomas D P, Faulkner K B, Tinsley J M. J Gen Virol. 1994;75:1125–1137. doi: 10.1099/0022-1317-75-5-1125. [DOI] [PubMed] [Google Scholar] · DOI
  30. [32]Ge N L, Elferink C J. J Biol Chem. 1998;273:22708–22713. doi: 10.1074/jbc.273.35.22708. [DOI] [PubMed] [Google Scholar] · DOI
  31. [33]Puga A, Barnes S J, Dalton T P, Chang C, Knudsen E S, Maier M A. J Biol Chem. 2000;275:2943–2950. doi: 10.1074/jbc.275.4.2943. [DOI] [PubMed] [Google Scholar] · DOI
  32. [34]Allen J R, Norback D H. Science. 1973;179:498–499. doi: 10.1126/science.179.4072.498. [DOI] [PubMed] [Google Scholar] · DOI
  33. [35]Morgan R W, Ward J M, Hartman P E. Cancer Res. 1981;41:5052–5059. [PubMed] [Google Scholar]

Cited by

Sorted by citations

Authors
Andersson, P., McGuire, J., Rubio, C., Gradin, K., Whitelaw, M. L., Pettersson, S., Hanberg, A., & Poellinger, L.
Affiliations
  • Karolinska Institutet (SE)
  • Department of Cell and Molecular Biology, Institute of Environmental Medicine, Department of Oncology-Pathology, and Microbiology and Tumor Biology Center, Karolinska Institute, S-171 77 Stockholm, Sweden; and Department of Biochemistry, University of Adelaide, South Australia 5005, Australia
Venue
Proceedings of the National Academy of Sciences
Published
2002-07-09
Volume
99
Issue
15
Pages
9990-9995
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2007225446
Cited by
310
References
2
Citations by year
2026: 4 · 2025: 8 · 2024: 4 · 2023: 11 · 2022: 12 · 2021: 13 · 2020: 14 · 2019: 19 · 2018: 15 · 2017: 13 · 2016: 17 · 2015: 11 · 2014: 12 · 2013: 18 · 2012: 15
FWCI
8.71
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Topics
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
Keywords
aryl hydrocarbon receptor, constitutively active receptor, stomach neoplasms, gastric cancer, oncogenicity, transgenic mice, xenobiotic metabolism, cell proliferation, polychlorinated dibenzo-p-dioxins, polycyclic aromatic hydrocarbons, transcription factors
MeSH terms
Polychlorinated Dibenzodioxins, Animals, Carcinogens, Cloning, Molecular, Cricetinae, Intestinal Neoplasms, Liver, Male, Mice, Inbred CBA, Mice, Inbred C57BL, Recombinant Proteins, Stomach Neoplasms, Thymus Gland, Transfection, CHO Cells, Receptors, Aryl Hydrocarbon, Gene Expression Regulation, Developmental, Cytochrome P-450 CYP1A1, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review